Walter Olesiak - Profile and Investment Details

Investor Profile

Walter Olesiak is a Venture Capital based in New York City, New York, United States with a diverse investment portfolio that includes companies such as OMEICOS Therapeutics, Omeicos Ophthalmics, Inc., Axikin Pharmaceuticals, Inc, ENB Therapeutics, Tranquis Therapeutics, Mitoconix Bio, Connectis Ventures, Cylene Pharmaceuticals, Inc., ProteinSimple (formerly Cell Biosciences, Inc.), Panacos Pharmaceuticals, Inc, Biolex Therapeutics, Inc., Cyrano Therapeutics, Cambridge Pharma Consultancy, Actimis Pharmaceuticals, Inc.i3 Asset Accelerator - Mount Sinai Health System, InFlectis BioScience, Cardeus Pharmaceuticals, Inc, LUCA Science, KisoJi Biotechnology, Boston Biomedical, Inc., . Over time, Walter Olesiak has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Walter Olesiak is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Regenerative Medicine, Wellness, Women Founded, Rare Diseases, Life Science, Engineering, Biotechnology, Drug Development, Productivity Software, Clinical Trials, Research, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Walter Olesiak, as their portfolio suggests a familiarity and interest in this area.

Understanding Walter Olesiak’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.